Edited By: Amit K. Tiwari, PhD
Cancer Reports is an international, open access oncology journal publishing basic, translational, clinical and interdisciplinary research in cancer biology, diagnosis, treatment, outcome, supportive care, epidemiology and health disparities. We encourage data-driven, scientifically valid findings, including incremental discoveries, pilot studies and more. With rapid publication and free format submission, we offer a simplified and streamlined submission process and are indexed with Web of Science and MEDLINE.
Cancer Reports just received a Journal Citation Indicator of 0.3, first Journal Impact Factor™ of 1.7 and CiteScore of 2.3. Thank you to all our Authors, Board Members, Reviewers, and other contributors!
On the Cover
Articles
The levels and trends of cancer incidence in the elderly population at national and sub‐national scales in Iran from 1990 to 2016
-  4 December 2023
A ferroptosis-related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study
-  3 December 2023
Identification of characteristics and construction of nomogram to predict the survival probability of mesonephric carcinoma patients: A population‐based analysis and a case report
-  29 November 2023
The possible role furin and furin inhibitors in endometrial adenocarcinoma: A narrative review
-  28 November 2023
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard‐dose azacitidine
-  28 November 2023
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer
-  6 January 2020
Pluronic micelles encapsulated curcumin manifests apoptotic cell death and inhibits pro‐inflammatory cytokines in human breast adenocarcinoma cells
-  24 September 2018
Resveratrol‐loaded nanomedicines for cancer applications
-  2 March 2021
Molecular and cellular paradigms of multidrug resistance in cancer
-  13 October 2020